Document is current
Any future updates will be listed below
-
Authors
Rodriguez-Mier, Pablo https://orcid.org/0000-0002-4938-4418
Garrido-Rodriguez, Martin
Gabor, Attila
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (951773, 965193, 951773, 965193, 951773)
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 2 June 2025
First Online: 22 July 2025
Competing interests
: J.-S.R. reports in the past 3 years funding from GSK and Pfizer and fees/honoraria from Travere Therapeutics, Stadapharm, Astex, Owkin, Pfizer, Grunenthal, Tempus AI and Moderna. A.G. receives fees and honoraria from Tempus AI and is currently an employee of Sanofi. The other authors declare no competing interests.
